Plus 5 New Strong Buys for Today Stocks Down As Market Hits Pause After Recent Highs
[Kevin Matras - EVP - Photo]
Profit from the Pros By Kevin Matras
Executive Vice President Stocks Down As Market Hits Pause After Recent Highs [Stocks Down As Market Hits Pause After Recent Highs]Image: Bigstock Stocks closed lower yesterday with all of the major indexes in the red. There was no 'one thing' that sent stocks down yesterday. We've seen a strong run-up in the previous weeks with the Dow, S&P, and small-cap Russell 2000 making new all-time highs. So you have some profit taking. And likely some continued sector rotation. We're also getting reports of stimulus check delays. Obviously, this is a short-term snafu. People who are supposed to get them will still get them. But it likely just added to the down market yesterday. Gladly, yields were down again with the 10-year losing -2.73% at 1.6380. Although, news of tax increases to pay for a likely $3 trillion infrastructure plan, probably isn't sitting well with some folks, which reportedly could include corporate tax hikes. On one hand, you have a massive amount of money for infrastructure, which should help the economy, but tax hikes would do the opposite. But for now, it's just talk. In the meantime, we've already got a massive amount of money that will be sloshing around in the economy with the stimulus. And that's expected to send growth soaring. Currently, Q1 GDP is forecast at 5.7%, while full-year GDP is expected to come in at the fastest pace in 33 years. And who can forget what JP Morgan Chase CEO, Jamie Dimon, said when commenting on the growth outlook if the stimulus bill passed (which we now know it did). He said "there's a very good chance you're going to have a gangbuster economy for the rest of this year and easily into 2022." Sounds pretty bullish. Today, on the report docket, we'll get MBA Mortgage Applications, Durable Goods Orders, and the PMI Composite Flash Index. We'll also hear from Fed Chair, Jerome Powell, as he testifies in front of the Senate Banking Committee when he discusses the Coronavirus Aid, Relief, and Economic Security Act. Use these pullbacks to your advantage. Because it looks like there's a lot more upside to go. See you tomorrow, [Kevin Matras - Signature] Kevin Matras
Executive Vice President, Zacks Investment Research Sponsor [SHOCKING: $100 Billion Surging Into the 5G Market]( What do Verizon, AT&T, T-Mobile, Dish Network, Charter Communications and Comcast have in common? According to Barron's, they're all participating in "secret bidding" to secure as much as $100 billion worth of 5G spectrum. The big winner in all of this frenzied spending? This little-known tech stock, which trades for less than $20 a share. [Get the scoop here...]( Most Popular Articles from Zacks.com [Read this article]( Image: Bigstock [Steel Industry Rides on Zooming Prices: 5 Red-Hot Stocks to Buy]( Skyrocketing prices and an upswing in demand from key end-use industries such as automotive and construction have pulled the industry out of its pandemic-induced slumber. [Read More »]( [Read this article]( Image: Bigstock [4 Top Home Appliance Stocks to Watch on Strong Consumer Demand Trends]( Stocks in this industry have collectively gained 156.3% outperforming the broader Consumer Discretionary sector and the S&P 500 Index over the past year. [Read More »]( [Read this article]( Image: Bigstock [6 Top-Ranked Stocks to Make the Most of 5G Uptrend]( We picked six stocks that are well-poised to benefit from solid growth in 5G infrastructure spending and accelerated proliferation. [Read More »]( [Read this article]( Image: Bigstock [3 ETFs to Invest in Cheapest Value Stocks]( Value is outperforming growth this year, here's why [Read More »]( [Read this article]( Image: Bigstock [Sports Betting ETFs to Rally on March Madness Gambling]( With increased legalization of online sports betting, this year's tournament will be the most wagered-on sporting event in history. [Read More »]( Sponsor [Breakout Biotech Stocks with Triple-Digit Profit Potential]( The Biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They're also finding ways to edit DNA to literally erase our vulnerability to these diseases. Senior Stock Strategist Kevin Cook wrote The Century of Biology (3rd Edition) to help investors profit from 7 stocks with impressive upside potential. Cook's recommendations in the 2nd Edition of this report soared as much as +205%... +258%... even +477% in just months. The stocks in this report could produce even better returns. Don't delay: The Century of Biology is only available until Sunday, March 28. [See 7 Breakthrough Stocks Now »]( [Read this article]( Image: Bigstock [Bull of the Day: BHP Billiton (BBL)]( Commodity prices have been on the rise, meaning earnings are on the move for BBL. [Read More »]( [Read this article]( [New Zacks Strong Buys for March 24th]( Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today. [Read More »]( Download our app for convenient on-the-go access to even more—daily and weekly newsletters published by Zacks experts, proprietary research and tools, and Portfolio Tracker on Zacks.com. [Download our Zacks App for Apple iOS](
[Download our Zacks App for Android]( Visit [Success Stories]( to hear how Zacks research, tools and portfolios help our members outperform the market. Get all of our market insights and much more when you connect with us. [Visit Zacks on Facebook]( [Follow Zacks on Twitter]( [See Zacks videos on YouTube]( [Join Zacks on LinkedIn]( [Read Zacks Commentary on StockTwits]( This free resource is being sent by [Zacks.com](. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. [www.zacks.com/disclaimer](. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or US investment adviser or investment bank. The Zacks #1 Rank Performance covers the period beginning on January 1, 1988 through March 1, 2021. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank #1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit [( for information about the performance numbers displayed above. Zacks Emails
If you would prefer to not receive future profit-producing emails from [Zacks.com]( the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please [click here]( and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com. Zacks Investment Research
10 S. Riverside Plaza, Suite 1600
Chicago, IL 60606